| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8211820 | International Journal of Radiation Oncology*Biology*Physics | 2017 | 9 Pages |
Abstract
To our knowledge, this is the first study to demonstrate that PF can be reversed by a senolytic drug such as ABT-263 after it becomes a progressive disease. Therefore, ABT-263 has the potential to be developed as a new treatment for PF.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Jin PhD, Deguan PhD, Yanfeng PhD, Junling PhD, Yueying BS, Mengyi MS, Shuai MS, Lan BS, Eun Joo PhD, Deborah E. MD, Yingying PhD, Martin MD, PhD, Daohong MD, Aimin MD,